Danone Reports H1 Sales Growth Despite Infant Formula Recall
Danone said H1 sales rose, with APAC up 5.2% and the EDP division remaining its top earner. Specialized nutrition grew like-for-like by 3.2% despite recalls of several infant formula batches at the start of the year. The company says it is strengthening supply control and focusing on rebuilding confidence through safety, transparency, and execution.